Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› JAK1
JAK1
(3 companies · 3 programs)
Companies with an active program directed at JAK1.
Aclaris Therapeutics
ACRS
lepzacitinib
— Atopic Dermatitis
Phase 2
Acrivon Therapeutics
ACRV
ACR-525
— Eosinophilic Esophagitis
Phase 1
EyePoint, Inc.
EYPT
DURAVYU
— Diabetic Macular Edema
Phase 3